Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42,079,879
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
10,339,444
-
Shares change
-
+633,995
-
Total reported value, excl. options
-
$29,052,785
-
Value change
-
+$1,669,140
-
Number of buys
-
10
-
Number of sells
-
4
-
Price
-
$2.81
Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q4 2023
As of 31 Dec 2023 InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,339,444 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, MARSHALL WACE, LLP, Soleus Capital Management, L.P., Rosalind Advisors, Inc., Velan Capital Investment Management LP, PURA VIDA INVESTMENTS, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and Mesirow Financial Investment Management, Inc..
This table shows 27 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.